Concepts (133)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Papillomavirus Vaccines | 2 | 2018 | 405 | 0.99 | Why? |
| Papillomavirus Infections | 2 | 2018 | 861 | 0.79 | Why? |
| Models, Economic | 1 | 2018 | 316 | 0.59 | Why? |
| Epidemics | 6 | 2021 | 6407 | 0.55 | Why? |
| Infectious Disease Incubation Period | 5 | 2020 | 1033 | 0.51 | Why? |
| Cost-Benefit Analysis | 3 | 2018 | 2259 | 0.47 | Why? |
| Hong Kong | 9 | 2021 | 3361 | 0.45 | Why? |
| Forecasting | 3 | 2021 | 4492 | 0.40 | Why? |
| Interpersonal Relations | 1 | 2017 | 926 | 0.39 | Why? |
| Sexual Behavior | 1 | 2018 | 1322 | 0.38 | Why? |
| Disease Transmission, Infectious | 4 | 2020 | 9044 | 0.37 | Why? |
| Communicable Diseases, Emerging | 2 | 2021 | 2523 | 0.33 | Why? |
| Models, Statistical | 2 | 2020 | 5312 | 0.30 | Why? |
| Computer Simulation | 1 | 2020 | 4982 | 0.28 | Why? |
| Mutation | 1 | 2021 | 12376 | 0.21 | Why? |
| Respiratory Tract Infections | 2 | 2020 | 6817 | 0.20 | Why? |
| Genetic Markers | 1 | 2021 | 318 | 0.19 | Why? |
| Influenza A Virus, H2N2 Subtype | 1 | 2018 | 6 | 0.19 | Why? |
| Age Factors | 1 | 2020 | 21039 | 0.18 | Why? |
| Sex Ratio | 1 | 2018 | 69 | 0.18 | Why? |
| Markov Chains | 1 | 2020 | 502 | 0.17 | Why? |
| Internationality | 2 | 2020 | 3297 | 0.17 | Why? |
| Monte Carlo Method | 1 | 2020 | 577 | 0.17 | Why? |
| Hand, Foot and Mouth Disease | 1 | 2017 | 115 | 0.15 | Why? |
| Influenza, Human | 5 | 2020 | 10779 | 0.15 | Why? |
| Severity of Illness Index | 4 | 2020 | 48226 | 0.15 | Why? |
| Coronavirus Infections | 13 | 2020 | 253789 | 0.14 | Why? |
| Stomach Neoplasms | 1 | 2020 | 477 | 0.14 | Why? |
| History, 21st Century | 1 | 2021 | 1849 | 0.13 | Why? |
| Spike Glycoprotein, Coronavirus | 2 | 2021 | 37182 | 0.13 | Why? |
| Epidemiological Monitoring | 3 | 2021 | 3493 | 0.12 | Why? |
| Adolescent Behavior | 1 | 2018 | 400 | 0.12 | Why? |
| Communicable Diseases, Imported | 1 | 2020 | 843 | 0.12 | Why? |
| Communicable Disease Control | 2 | 2020 | 29620 | 0.11 | Why? |
| Influenza A Virus, H1N1 Subtype | 2 | 2020 | 2984 | 0.11 | Why? |
| Pandemics | 13 | 2021 | 389249 | 0.11 | Why? |
| Neutralization Tests | 2 | 2021 | 6698 | 0.10 | Why? |
| Child, Preschool | 6 | 2020 | 36283 | 0.10 | Why? |
| Uterine Cervical Neoplasms | 1 | 2018 | 842 | 0.10 | Why? |
| Models, Theoretical | 4 | 2021 | 6659 | 0.10 | Why? |
| Pneumonia, Viral | 9 | 2020 | 243684 | 0.10 | Why? |
| Adolescent | 9 | 2020 | 86841 | 0.10 | Why? |
| China | 7 | 2020 | 50654 | 0.10 | Why? |
| Basic Reproduction Number | 1 | 2021 | 2676 | 0.10 | Why? |
| Endoscopy, Gastrointestinal | 1 | 2020 | 1545 | 0.09 | Why? |
| Child | 7 | 2020 | 70012 | 0.09 | Why? |
| Infant | 4 | 2020 | 30274 | 0.09 | Why? |
| Immunization Programs | 1 | 2021 | 2006 | 0.09 | Why? |
| Travel | 3 | 2021 | 7220 | 0.09 | Why? |
| Humans | 28 | 2021 | 930598 | 0.09 | Why? |
| Asymptomatic Diseases | 1 | 2020 | 3444 | 0.08 | Why? |
| Seroepidemiologic Studies | 2 | 2020 | 10017 | 0.08 | Why? |
| Prevalence | 2 | 2020 | 25773 | 0.08 | Why? |
| Politics | 1 | 2020 | 1824 | 0.08 | Why? |
| Cost of Illness | 1 | 2017 | 1903 | 0.08 | Why? |
| Genetic Variation | 1 | 2021 | 3919 | 0.08 | Why? |
| Quality of Life | 2 | 2017 | 9820 | 0.08 | Why? |
| Colorectal Neoplasms | 1 | 2020 | 1884 | 0.08 | Why? |
| Serologic Tests | 1 | 2020 | 4359 | 0.07 | Why? |
| Mortality | 2 | 2020 | 7132 | 0.07 | Why? |
| Disease Outbreaks | 3 | 2021 | 27595 | 0.07 | Why? |
| Clinical Laboratory Techniques | 3 | 2020 | 23402 | 0.07 | Why? |
| Enzyme-Linked Immunosorbent Assay | 1 | 2020 | 7868 | 0.07 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 2 | 2016 | 8843 | 0.07 | Why? |
| Reproducibility of Results | 1 | 2021 | 11304 | 0.07 | Why? |
| Male | 13 | 2021 | 367725 | 0.07 | Why? |
| Survival Rate | 1 | 2018 | 9206 | 0.07 | Why? |
| Real-Time Polymerase Chain Reaction | 2 | 2020 | 11367 | 0.07 | Why? |
| Female | 13 | 2021 | 380317 | 0.06 | Why? |
| Incidence | 3 | 2020 | 25622 | 0.06 | Why? |
| Phylogeny | 1 | 2021 | 13341 | 0.06 | Why? |
| Betacoronavirus | 9 | 2020 | 204454 | 0.06 | Why? |
| Sex Factors | 1 | 2018 | 11014 | 0.05 | Why? |
| Aged | 9 | 2020 | 215776 | 0.05 | Why? |
| Adult | 10 | 2020 | 244371 | 0.05 | Why? |
| United Kingdom | 1 | 2021 | 18046 | 0.05 | Why? |
| Middle Aged | 9 | 2020 | 270681 | 0.05 | Why? |
| Genome, Viral | 1 | 2021 | 13157 | 0.05 | Why? |
| Hospitalization | 5 | 2020 | 54280 | 0.04 | Why? |
| Public Health | 2 | 2021 | 16359 | 0.04 | Why? |
| Telephone | 2 | 2017 | 1705 | 0.04 | Why? |
| Wisconsin | 1 | 2020 | 607 | 0.04 | Why? |
| Spatial Regression | 1 | 2018 | 67 | 0.04 | Why? |
| Contact Tracing | 1 | 2017 | 8448 | 0.04 | Why? |
| Immune Sera | 1 | 2021 | 884 | 0.04 | Why? |
| Prognosis | 1 | 2020 | 32490 | 0.04 | Why? |
| Quality-Adjusted Life Years | 1 | 2017 | 511 | 0.03 | Why? |
| Aged, 80 and over | 3 | 2020 | 88759 | 0.03 | Why? |
| Cats | 1 | 2021 | 1890 | 0.03 | Why? |
| Republic of Korea | 2 | 2016 | 5858 | 0.03 | Why? |
| Dogs | 1 | 2021 | 2529 | 0.03 | Why? |
| Cricetinae | 1 | 2021 | 3344 | 0.03 | Why? |
| Neoplasm Staging | 1 | 2020 | 1999 | 0.03 | Why? |
| Young Adult | 6 | 2020 | 93724 | 0.03 | Why? |
| Vaccination | 1 | 2018 | 19050 | 0.03 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2015 | 12361 | 0.03 | Why? |
| Logistic Models | 2 | 2018 | 9089 | 0.03 | Why? |
| Demography | 1 | 2018 | 1660 | 0.03 | Why? |
| Databases, Factual | 2 | 2017 | 6248 | 0.03 | Why? |
| Risk Assessment | 3 | 2020 | 25439 | 0.03 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.03 | Why? |
| New York | 1 | 2018 | 2488 | 0.03 | Why? |
| Coronavirus | 1 | 2020 | 18339 | 0.03 | Why? |
| Cross Reactions | 1 | 2021 | 4374 | 0.02 | Why? |
| Health Policy | 1 | 2009 | 6242 | 0.02 | Why? |
| Interviews as Topic | 1 | 2017 | 1952 | 0.02 | Why? |
| Neuraminidase | 1 | 2009 | 289 | 0.02 | Why? |
| Immunity | 1 | 2018 | 2651 | 0.02 | Why? |
| Animals | 3 | 2021 | 78931 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2015 | 4260 | 0.02 | Why? |
| Bayes Theorem | 1 | 2015 | 3237 | 0.02 | Why? |
| Saudi Arabia | 1 | 2016 | 4423 | 0.02 | Why? |
| Self Report | 1 | 2017 | 3802 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2020 | 6740 | 0.02 | Why? |
| Vero Cells | 1 | 2020 | 14117 | 0.02 | Why? |
| Drug Resistance, Viral | 1 | 2009 | 1083 | 0.02 | Why? |
| Caregivers | 1 | 2017 | 3112 | 0.02 | Why? |
| Ambulatory Care | 1 | 2017 | 4947 | 0.01 | Why? |
| Surveys and Questionnaires | 2 | 2017 | 43792 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.01 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.01 | Why? |
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 8811 | 0.01 | Why? |
| Antiviral Agents | 1 | 2009 | 41703 | 0.01 | Why? |
| Australia | 1 | 2009 | 6306 | 0.01 | Why? |
| Hospital Mortality | 1 | 2020 | 22087 | 0.01 | Why? |
| Infant, Newborn | 1 | 2016 | 23105 | 0.01 | Why? |
| Quarantine | 1 | 2021 | 18418 | 0.01 | Why? |
| Antibodies, Neutralizing | 1 | 2021 | 25288 | 0.01 | Why? |
| Depression | 1 | 2017 | 14116 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2020 | 53120 | 0.01 | Why? |
| Anxiety | 1 | 2017 | 17311 | 0.01 | Why? |
| Infection Control | 1 | 2020 | 23131 | 0.01 | Why? |
| Retrospective Studies | 1 | 2017 | 105322 | 0.00 | Why? |
Wu's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(133)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(126)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_